Research output per year
Research output per year
-
Mitä on purinerginen signalointi ja miksi se on tärkeää?
Helenius, M., 2020, In: Kliin lab : kliinisen laboratorioalan julkaisu : SKKY:n jäsenlehti.. 37, 5, p. 159-161 3 p.Research output: Contribution to journal › Article › Professional
Open Access -
Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers
Bulanova, D. R., Helenius, M., Sokolenko, A. P., Kuznetsov, S. G. & Imyanitov, E. N., 1 Apr 2019, In: International Journal of Cancer. 144, 7, p. 1758-1760 3 p.Research output: Contribution to journal › Letter › Scientific
Open AccessFile -
BRCA1-deficient breast cancer cell lines are resistant to MEK inhibitors and show distinct sensitivities to 6-thioguanine
Gu, Y., Helenius, M., Vaananen, K., Bulanova, D., Saarela, J., Sokolenko, A., Martens, J., Imyanitov, E. & Kuznetsov, S., 17 Jun 2016, In: Scientific Reports. 6, 9 p., 28217.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Suppression of endothelial CD39/ENTPD1 is associated with pulmonary vascular remodeling in pulmonary arterial hypertension
Helenius, M. H., Vattulainen, S., Orcholski, M., Aho, J., Komulainen, A., Taimen, P., Wang, L., Perez, V. A. D. J., Koskenvuo, J. W. & Alastalo, T-P., 15 May 2015, In: American Journal of Physiology. Lung Cellular and Molecular Physiology. 308, 10, p. L1046-L1057 12 p.Research output: Contribution to journal › Article › Scientific › peer-review
-
Loss of Bone Morphogenetic Protein Receptor 2 Is Associated with Abnormal DNA Repair in Pulmonary Arterial Hypertension
Li, M., Vattulainen, S., Aho, J., Orcholski, M., Rojas, V., Yuan, K., Helenius, M., Taimen, P., Myllykangas, S., Perez, V. D. J., Koskenvuo, J. W. & Alastalo, T-P., Jun 2014, In: American Journal of Respiratory Cell and Molecular Biology. 50, 6, p. 1118-1128 11 p.Research output: Contribution to journal › Article › Scientific › peer-review